Sign In
Last checked at 
14 Sep 2022 16:33
FOR RELEASE ON | 14 September 2022 |
IP Group plc - Further re Scrip Dividend
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces that, further to the announcements dated 03 August 2022, 18 August 2022 and 13 September 2022 in connection with the Interim Scrip Dividend, the Group has received valid elections from shareholders resulting in a requirement to issue 154,718 new ordinary shares of 2p each ("New Shares").
An application has been made for the New Shares to be issued in connection with the Scrip Dividend to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange respectively.
Admission of the New Shares is expected to be effective on 20 September 2022. Following admission and in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Group will have 1,063,188,005 Ordinary Shares in issue and 28,607,622 Ordinary Shares in Treasury.
The total number of Ordinary Shares with voting rights following the issue of the New Shares will be 1,034,580,383 Ordinary Shares. This figure may be used by shareholders in the Group as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Group under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.
For more information, please contact:
IP Group plc | www.ipgroupplc.com |
David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications | +44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
Follow the stocks
